Insider trading on Orchard Therapeutics acquisition by Kyowa Kirin may raise regulatory scrutiny or reputational concerns.
Impact on assets 1
Theme Impact
Off-coverage companies 3
CEO pleaded guilty to insider trading, damaging company reputation and leadership credibility.
Insider trading on Sixth Street's acquisition of Enstar may raise regulatory scrutiny or reputational concerns.